Talphera (NASDAQ:TLPH) Stock Price Up 1.7%

Talphera, Inc. (NASDAQ:TLPHGet Free Report)’s stock price rose 1.7% during trading on Tuesday . The stock traded as high as $1.02 and last traded at $0.95. Approximately 20,477 shares traded hands during trading, a decline of 83% from the average daily volume of 119,366 shares. The stock had previously closed at $0.93.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $6.00 target price on shares of Talphera in a report on Thursday, March 7th.

Read Our Latest Research Report on TLPH

Talphera Trading Up 1.7 %

The stock has a market capitalization of $16.05 million, a price-to-earnings ratio of -0.64 and a beta of 0.51. The company’s fifty day moving average price is $1.15.

Talphera (NASDAQ:TLPHGet Free Report) last issued its earnings results on Wednesday, March 6th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by ($0.01). The firm had revenue of $0.28 million for the quarter. As a group, equities analysts predict that Talphera, Inc. will post -1.12 EPS for the current year.

Talphera Company Profile

(Get Free Report)

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.

Recommended Stories

Receive News & Ratings for Talphera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talphera and related companies with MarketBeat.com's FREE daily email newsletter.